PTC Therapeutics
PTCT
PTCT
202 hedge funds and large institutions have $3.47B invested in PTC Therapeutics in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
202
Holders Change
–
Holders Change %
0%
% of All Funds
4.15%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.12%
New
28
Increased
88
Reduced
58
Closed
26
Calls
$34.6M
Puts
$15.8M
Net Calls
+$18.8M
Net Calls Change
-$22.1M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$92.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$90.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$41.2M |
| 4 |
BlackRock
New York
|
+$27.4M |
| 5 |
BAMCO Inc
New York
|
+$25.7M |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$72.7M |
| 2 |
O
OrbiMed
New York
|
-$51.2M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$44.4M |
| 4 |
Renaissance Technologies
New York
|
-$19M |
| 5 |
Two Sigma Investments
New York
|
-$8.15M |
